To Study the Efficacy of Bromocriptine in Patients With Hepatic/Cirrhosis Related Parkinsonism
Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
After successful screening of liver cirrhosis patients attending ILBS OPD for signs of
parkinsonism ( tremor, rigidity or bradykinesia, any 2 of 3). Diagnosis of hepatic/cirrhosis
related parkinsonism will be made. Patients will be randomized into Bromocriptine and
Placebo. Patients will be followed up every month in OPD (Out Patient Department), ILBS
(Institute of liver & Biliary Sciences) for 3 months. Detailed neurological examination will
be done at each visit & UPDRS (Unified Parkinson's Disease Rating Scale ) score will be
calculated.